TUCSON
520.748.4400
About Us
Professional Staff
Board of Directors
Careers
Contact Us
Frederick Gardner
Cottrell Foundation
Successes
Ventures
Biotechnology
Medical Devices
Other
Historic Investments
Technologies
The CH2 Domain Scaffold – ABDURINS™
Deimmunized Sarcin Ribotoxin
Endotoxin-free ClearColi™ Expression System
Fibronectin Artificial Antibody Scaffold
Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)
Pichia Classic Expression Platform
Pichia GlyoSwitch™ Protein Expression System
Ultrasound Tissue Harmonic Imaging
VIMPAT® (lacosamide) for Treatment of Epileptic Seizures
Innovate With Us
News & Events
Home
»
News & Events
»
2019
Spencer Health Solution’s Breakthrough Direct-to-Patient Technology Achieves 97% Medication Adherence
11.21.2019
Femtogenix Presents Novel Data on Antibody Drug Conjugates Containing Reduced Potency Payloads in Solid Tumour Models
10.29.2019
Q’Apel Medical Announces FDA Clearance for Walrus Balloon Guide Catheter
7.17.2019
CyMedica Launches e-vive™ Clinical Trial for Knee Osteoarthritis Utilizing Smartwatch Technology
6.4.2019
OrthAlign, Inc. Announces Launch of HipAlign® Application for Surgical Navigation in Total Hip Arthroplasty
5.30.2019
ClearFlow Announces Positive Randomized Controlled Trial Results and Inclusion in ERAS Guideline Recommendations
5.7.2019
Femtogenix and Iksuda Therapeutics sign license agreement
3.5.2019
Halo Labs Raises $5.6M in Series B Financing Round Led by RCT
1.3.2019
News by Year
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
From concept
to market
Innovate with us ›